B Munos

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi Can open-source R&D reinvigorate drug research?
    Bernard Munos
    Bernard Munos is at Eli Lilly and Co, Lilly Corporate Center, 1085, Indianapolis, Indiana 46285, USA
    Nat Rev Drug Discov 5:723-9. 2006
  2. ncbi Can open-source drug R&D repower pharmaceutical innovation?
    B Munos
    Corporate Strategy, Eli Lilly and Company, Indianapolis, Indiana, USA
    Clin Pharmacol Ther 87:534-6. 2010
  3. ncbi How to revive breakthrough innovation in the pharmaceutical industry
    Bernard H Munos
    InnoThink Center for Research in Biomedical Innovation, Indianapolis, IN 46228 1422, USA
    Sci Transl Med 3:89cm16. 2011

Detail Information

Publications3

  1. ncbi Can open-source R&D reinvigorate drug research?
    Bernard Munos
    Bernard Munos is at Eli Lilly and Co, Lilly Corporate Center, 1085, Indianapolis, Indiana 46285, USA
    Nat Rev Drug Discov 5:723-9. 2006
    ..Can open-source drug research and development, using principles pioneered by the highly successful open-source software movement, help revive the industry?..
  2. ncbi Can open-source drug R&D repower pharmaceutical innovation?
    B Munos
    Corporate Strategy, Eli Lilly and Company, Indianapolis, Indiana, USA
    Clin Pharmacol Ther 87:534-6. 2010
    ..Is open innovation the answer to the innovation crisis? This Commentary argues that although it may likely be part of the solution, significant cultural, scientific, and regulatory barriers can prevent it from delivering on its promise...
  3. ncbi How to revive breakthrough innovation in the pharmaceutical industry
    Bernard H Munos
    InnoThink Center for Research in Biomedical Innovation, Indianapolis, IN 46228 1422, USA
    Sci Transl Med 3:89cm16. 2011
    ....